Insider · CIK 0001704186
Kimberly Gentile
officer
Files at BHVN (Biohaven Ltd.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | BHVN Biohaven Ltd. | AGrant or award Stock Options (Right to buy)derivativeindirect: By Son | +1,000 | $0.00 | $0 | 1,000 | 25 d ago |
| Jan 5, 2025 | BHVN Biohaven Ltd. | MOption exercise Common Shares | +3,750 | $0.00 | $0 | 99,719 | Jan 7, 2025 |
| Jan 5, 2025 | BHVN Biohaven Ltd. | FTax withholding Common Shares | -1,956 | $38.64 | $76k | 97,763 | Jan 7, 2025 |
| Jan 5, 2025 | BHVN Biohaven Ltd. | AGrant or award Stock Options (Right to buy)derivative | +91,000 | $0.00 | $0 | 91,000 | Jan 7, 2025 |
| Jan 5, 2025 | BHVN Biohaven Ltd. | AGrant or award Restricted Share Unit Awardderivative | +15,000 | $0.00 | $0 | 15,000 | Jan 7, 2025 |
| Jan 5, 2025 | BHVN Biohaven Ltd. | MOption exercise Restricted Share Unit Awardderivative | -3,750 | $0.00 | $0 | 11,250 | Jan 7, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.